Internal Medicine, Gastroenterology · Alabaster, AL
NPI
1487608881
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1010 1st St N, Suite 112
Alabaster, AL, 35007
Phone (205) 663-1023
Groups this clinician bills Medicare through
Medicare paid, 2024
$309K
15,853 services
Medicare patients, 2024
306
Average age 73
Drug cost, 2024
$1.4M
2,083 prescriptions
Company payments, 2025
$1,716
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert D Loudon was code J3380 (injection, vedolizumab, intravenous, 1 mg), 12,300 times for 20 patients. In total Robert D Loudon billed 15,853 services in 47 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 12,300 | 20 | $17.39 | $214K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,180 | 13 | $24.71 | $29K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 110 | 29 | $34.67 | $3,813 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 93 | 30 | $45.03 | $4,188 |
| 45380 Lower GI Endoscopy - Other | Facility | 85 | 85 | $69.80 | $5,933 |
| 45385 Colonoscopy - Lesion Removal | Facility | 74 | 74 | $188.11 | $14K |
| 43239 Upper GI Endoscopy | Facility | 66 | 64 | $51.10 | $3,373 |
| 99214 Office E&M - Established | Office | 45 | 34 | $86.14 | $3,876 |
| 96365 Intravenous Infusion, Hydration | Office | 41 | 20 | $42.93 | $1,760 |
| 99213 Office E&M - Established | Office | 35 | 33 | $56.91 | $1,992 |
| 43235 Upper GI Endoscopy | Facility | 27 | 25 | $70.26 | $1,897 |
| 96413 Chemotherapy Administration | Office | 21 | 13 | $88.21 | $1,852 |
| 43249 Upper GI Endoscopy | Facility | 20 | 20 | $98.04 | $1,961 |
| 99204 Office E&M - New | Office | 16 | 16 | $93.91 | $1,503 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 16 | 16 | $158.26 | $2,532 |
By year: 2022 $234K for 10,327 services; 2023 $278K for 14,025 services; 2024 $309K for 15,853 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert D Loudon prescribed most often to Medicare patients was Pantoprazole Sodium, with 668 prescriptions and refills. In total Robert D Loudon wrote 2,083 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 668 | 1,355 | 227 | $7,636 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 230 | 230 | 226 | $14K |
| Linzess Linaclotide | 137 | 173 | 36 | $89K |
| Dicyclomine Hcl Generic | 96 | 140 | 36 | $1,967 |
| Omeprazole Generic | 84 | 167 | 31 | $1,220 |
| Ondansetron Hcl Generic | 65 | 66 | 22 | $862 |
| Sucralfate Generic | 57 | 83 | 26 | $2,572 |
| Dexlansoprazole Dr Dexlansoprazole | 50 | 110 | 16 | $17K |
| Colestipol Hcl Generic | 48 | 78 | 21 | $3,312 |
| Esomeprazole Magnesium Generic | 43 | 96 | 18 | $2,379 |
| Metoclopramide Hcl Generic | 42 | 48 | 11 | $194 |
| Famotidine Generic | 39 | 87 | 16 | $496 |
| Mesalamine Generic | 30 | 36 | Under 11 | $8,846 |
| Stelara Ustekinumab | 28 | 49 | Under 11 | $790K |
| Methscopolamine Bromide Generic | 27 | 37 | 12 | $3,539 |
Brand drugs: - claims; generic drugs: 1,621 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert D Loudon $1,716 ($1,716 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $447.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $447 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 20 | $388 |
| Janssen Biotech, Inc. JNJ | 13 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $192 |
| Lilly USA, LLC LLY | 8 | $143 |
| Ardelyx, Inc. ARDX | 3 | $64.87 |
| QOL Medical, LLC | 2 | $53 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $45.18 |
| Pfizer Inc. PFE | 2 | $37.43 |
| Celltrion USA Inc. 068270.KS | 2 | $36.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.